Growth Metrics

Neogen (NEOG) EBIAT (2016 - 2026)

Neogen has reported EBIAT over the past 17 years, most recently at -$17.0 million for Q1 2026.

  • For Q1 2026, EBIAT fell 55.96% year-over-year to -$17.0 million; the TTM value through Feb 2026 reached -$608.8 million, down 25.48%, while the annual FY2025 figure was -$1.1 billion, 11491.59% down from the prior year.
  • EBIAT for Q1 2026 was -$17.0 million at Neogen, down from -$15.9 million in the prior quarter.
  • Over five years, EBIAT peaked at $36.3 million in Q3 2025 and troughed at -$612.2 million in Q2 2025.
  • A 5-year average of -$64.7 million and a median of -$3.5 million in 2023 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: crashed 12985.75% in 2024 and later skyrocketed 388.1% in 2025.
  • Year by year, EBIAT stood at -$41.8 million in 2022, then skyrocketed by 91.67% to -$3.5 million in 2023, then crashed by 12985.75% to -$456.3 million in 2024, then soared by 96.52% to -$15.9 million in 2025, then dropped by 6.92% to -$17.0 million in 2026.
  • Business Quant data shows EBIAT for NEOG at -$17.0 million in Q1 2026, -$15.9 million in Q4 2025, and $36.3 million in Q3 2025.